Market capitalization | $242.09m |
Enterprise Value | $233.63m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 14.58 |
EV/Sales (TTM) EV/Sales | 1.10 |
P/S ratio (TTM) P/S ratio | 1.14 |
P/B ratio (TTM) P/B ratio | negative |
Revenue growth (TTM) Revenue growth | 39.27% |
Revenue (TTM) Revenue | $212.45m |
As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.
9 Analysts have issued a LifeMD forecast:
9 Analysts have issued a LifeMD forecast:
Dec '24 |
+/-
%
|
||
Revenue | 212 212 |
39%
39%
|
|
Gross Profit | 178 178 |
41%
41%
|
|
EBITDA | -6.65 -6.65 |
16%
16%
|
EBIT (Operating Income) EBIT | -16 -16 |
11%
11%
|
Net Profit | -19 -19 |
8%
8%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
LifeMD, Inc. is a telehealth company, which engages in offering portfolio of direct-to-patient products and services. It combines virtual medical treatment with prescription medications and over-the-counter products. The firm's network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States. The company's brands include Shapiro, Rex, and Nava. LifeMD was founded in 1987 and is headquartered in New York, NY.
Head office | United States |
CEO | Justin Schreiber |
Employees | 336 |
Founded | 1987 |
Website | www.lifemd.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.